Skip to content

Clinical trials

Completed Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Completed Country / region: China Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20081
20091
20111
20121
20133
20141
20151
20171
20181
20192
20201
20211
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Bristol-Myers Squibb4
Pfizer3
Ascentage Pharma Group Inc.2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
Shenzhen TargetRx Co., Ltd.2
Nanfang Hospital, Southern Medical University1
Otsuka Beijing Research Institute1
The First Affiliated Hospital of Soochow University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive21
Leukemia3
Philadelphia Chromosome3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Bronchiolitis Obliterans Syndrome2
Gastrointestinal Stromal Tumors1
Leukemia, Biphenotypic, Acute1
Leukemia, Myeloid, Acute1
Leukemia, Myeloid, Chronic-Phase1
Myelodysplastic Syndromes1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.